The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Update: PEP for Non-Occupational Exposure to HIV Guideline (5/23/18)
- Update: PEP for Occupational Exposure to HIV Guideline (5/23/18)
- Update: PEP for Victims of Sexual Assault Guideline (5/23/18)
- Update: PrEP to Prevent HIV Acquisition (5/17/18)
- May Topics, Trends, and Updates (5/10/18)
- Medscape Commentary: Syphilis Screening: Make it Routine in HIV Care (4/25/18)
- Update: Immunizations for Non-Pregnant Adults with HIV (4/13/18)
- Pocket Guide to HCV Diagnosis and Pre-Treatment Assessment (4/13/18)
- FDA Announces Availability of Draft Guidance for HIV-1 Infection: Developing Systemic Drug Products for PrEP (6/14/18)
- AIDSinfo: NLM-Authored Journal Article Describes Trends in HIV Language Use (6/14/18)
- AETC NCRC Updates (6/12/18)
- FDA: Prezcobix Pregnancy Label Updates (6/5/18)
- HHS Antiretroviral Guidelines Panels Issue Recommendations Regarding the Use of Dolutegravir (5/30/18)
Is High-Sensitivity CRP a Useful Cardiovascular Risk Predictor for Women with HIV? Risk of cardiovascular disease (CVD) and ischemic stroke in women with HIV appears to be greater than in men with HIV and in women who do not have HIV. Read more
Chronic Comorbidities among People Living with HIV Infection: As a result of potent and tolerable antiretroviral therapy (ART), people with HIV infection (PLWH) are living longer. However, rates of chronic, non-communicable end-organ diseases are higher in PLWH than in people of similar ages who do not have HIV infection. Read more
- CEI Newsletter (6/5/18)
- Access the New AIDS Institute Provider Directory (5/22/18)
- Updated Questions & Answers about HIV/AIDS Booklet (5/22/18)
- NYS Dear Colleague Letter: Relationship Between Opioid Crisis & Rise in New HCV Cases (3/31/2018)
- Governor Cuomo Announces Statewide Expansion of Enhanced Rental Assistance Program To Increase Access To Affordable Housing For New Yorkers Living With HIV/AIDS (3/16/18)
- 6/25/18: CEI: PrEP for HIV Prevention in Primary Care Settings (Watertown, NY)
- 7/21/18: STI 2018: Understanding & Addressing the HIV & STI Syndemics (Amsterdam, NL)
- 7/22/18: TB 2018 (Amsterdam, NL)
- 7/23/18: International AIDS Conference 2018 (Amsterdam, NL)
- 8/17/18: CEI: From Stigma to Action: Addressing Substance Use, Harm Reduction & Healthcare (New York, NY)